Impact of Maternal Aspirin Therapy on Neonatal Epigenetic Patterns
American Journal of Perinatology · 01.07.2026 · 43 (09) · 1156-1162
DOI: 10.1055/a-2721-5822 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.07.2026. Verfasst von Dante Varotsis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelp…. Hauptthemen laut MEDLINE: Aspirin, DNA Methylation, Fetal Blood, Epigenesis, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Low-dose aspirin (LDA) is an intervention recommended to prevent the development of hypertensive disorders of pregnancy (HDP) in high-risk pregnancies. Maternal conditions such as HDP have been associated with cord blood epigenetic changes including those related to cardiovascular processes; however, it is unclear whether maternal aspirin therapy may impact neonatal epigenetics in otherwise healthy high-risk pregnancy. This study aimed to determine if maternal LDA exposure in utero leads to altered DNA methylation in umbilical cord blood cells in term neonates compared with controls not exposed to aspirin, and to identify if these methylation changes alter key pathways in the development of chronic disease. Umbilical cord blood was collected from 10 neonates without LDA exposure and 13 neonates with LDA exposure in utero. Patients with hypertensive disorders of pregnancy, COVID-19, and chorioamnionitis were excluded. Genomic DNA was isolated from umbilical cord blood cells and genome-wide DNA methylation was performed using Illumina Methylation EPIC assay. A total of 155 differentially methylated loci (81 genes were hypermethylated and 74 were hypomethylated) were identified in LDA-exposed neonatal umbilical cord blood compared with the control group. Important canonical pathways identified by Ingenuity Pathway Analysis (IPA) were related to Th1 and Th2 signaling and classical (M1) macrophage activation. The genes affected by LDA exposure were associated with cardiac and renal systems. LDA exposure led to differential DNA methylation in umbilical cord blood. The differentially methylated genes were related to inflammatory pathways as well as cardiac and renal toxicity pathways. LDA exposure in utero may promote altered health programming in the neonate in areas impacting cardiovascular health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
- Nemours Children's Health, Wilmington, Delaware, United States.
- Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
ORCID-Profile: Rupsa C Boelig
Förderung
- NICHD NIH HHS
Zitieren
APA
Varotsis, D., Betal, S. G. N., Addya, S., Aghai, Z. H., & Boelig, R. C. (2026). Impact of Maternal Aspirin Therapy on Neonatal Epigenetic Patterns. American Journal of Perinatology, 43(09), 1156-1162. https://doi.org/10.1055/a-2721-5822
Vancouver
Varotsis D, Betal SGN, Addya S, Aghai ZH, Boelig RC. Impact of Maternal Aspirin Therapy on Neonatal Epigenetic Patterns. American Journal of Perinatology. 2026;43(09):1156-1162. doi:10.1055/a-2721-5822
BibTeX
@article{Varotsis2026,
author = {Varotsis, Dante and Betal, Suhita Gayen Nee and Addya, Sankar and Aghai, Zubair H and Boelig, Rupsa C},
title = {Impact of Maternal Aspirin Therapy on Neonatal Epigenetic Patterns},
journal = {American Journal of Perinatology},
year = {2026},
volume = {43},
number = {09},
pages = {1156--1162},
doi = {10.1055/a-2721-5822}
}
EUVIMED